Rock Springs Capital Management as of June 30, 2017
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 148 positions in its portfolio as reported in the June 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Tesaro | 3.5 | $69M | 491k | 139.86 | |
Acadia Healthcare (ACHC) | 3.4 | $67M | 1.4M | 49.38 | |
Aetna | 3.0 | $59M | 388k | 151.83 | |
UnitedHealth (UNH) | 2.9 | $58M | 314k | 185.42 | |
Alexion Pharmaceuticals | 2.8 | $56M | 463k | 121.67 | |
Pacira Pharmaceuticals (PCRX) | 2.5 | $50M | 1.0M | 47.70 | |
Merck & Co (MRK) | 2.5 | $49M | 758k | 64.09 | |
CIGNA Corporation | 2.3 | $45M | 270k | 167.39 | |
Intuitive Surgical (ISRG) | 2.3 | $45M | 48k | 935.38 | |
Radius Health | 2.1 | $41M | 910k | 45.23 | |
Allergan | 1.9 | $38M | 156k | 243.09 | |
Spark Therapeutics | 1.9 | $37M | 625k | 59.74 | |
Gw Pharmaceuticals Plc ads | 1.9 | $37M | 366k | 100.25 | |
WellCare Health Plans | 1.8 | $36M | 198k | 179.56 | |
Medtronic (MDT) | 1.8 | $36M | 400k | 88.75 | |
Pra Health Sciences | 1.8 | $35M | 463k | 75.01 | |
Advanced Accelerat spon ads each rep 2 ord | 1.7 | $33M | 840k | 39.04 | |
Humana (HUM) | 1.6 | $32M | 133k | 240.62 | |
Celgene Corporation | 1.6 | $32M | 245k | 129.87 | |
Penumbra (PEN) | 1.4 | $27M | 311k | 87.75 | |
Medicines Company | 1.3 | $26M | 694k | 38.01 | |
Theravance Biopharma (TBPH) | 1.2 | $24M | 600k | 39.84 | |
Johnson & Johnson (JNJ) | 1.2 | $23M | 175k | 132.29 | |
Loxo Oncology | 1.2 | $23M | 288k | 80.19 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.1 | $23M | 1.8M | 12.51 | |
Edwards Lifesciences (EW) | 1.1 | $23M | 190k | 118.24 | |
Almost Family | 1.1 | $22M | 362k | 61.65 | |
Gilead Sciences (GILD) | 1.1 | $22M | 313k | 70.78 | |
Incyte Corporation (INCY) | 1.1 | $22M | 173k | 125.91 | |
Clovis Oncology | 1.1 | $22M | 232k | 93.63 | |
Mersana Therapeutics (MRSN) | 1.1 | $21M | 1.5M | 13.97 | |
Thermo Fisher Scientific (TMO) | 1.0 | $19M | 110k | 174.47 | |
Neurocrine Biosciences (NBIX) | 1.0 | $19M | 419k | 46.00 | |
Jazz Pharmaceuticals (JAZZ) | 1.0 | $19M | 124k | 155.50 | |
Hologic (HOLX) | 1.0 | $19M | 420k | 45.38 | |
Danaher Corporation (DHR) | 1.0 | $19M | 225k | 84.39 | |
Wright Medical Group Nv | 0.9 | $18M | 670k | 27.49 | |
C.R. Bard | 0.9 | $18M | 58k | 316.10 | |
Molina Healthcare (MOH) | 0.9 | $18M | 264k | 69.18 | |
Epizyme | 0.9 | $18M | 1.2M | 15.10 | |
Amarin Corporation (AMRN) | 0.9 | $17M | 4.3M | 4.03 | |
Galapagos Nv- (GLPG) | 0.9 | $17M | 222k | 76.52 | |
Prothena (PRTA) | 0.8 | $17M | 310k | 54.12 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $17M | 129k | 128.87 | |
Puma Biotechnology (PBYI) | 0.8 | $16M | 186k | 87.40 | |
Willis Towers Watson (WTW) | 0.8 | $16M | 110k | 145.46 | |
Portola Pharmaceuticals | 0.8 | $16M | 280k | 56.17 | |
EXACT Sciences Corporation (EXAS) | 0.8 | $16M | 438k | 35.37 | |
Biogen Idec (BIIB) | 0.7 | $14M | 53k | 271.36 | |
Paratek Pharmaceuticals | 0.7 | $15M | 600k | 24.10 | |
Avexis | 0.7 | $14M | 175k | 82.16 | |
Baxter International (BAX) | 0.7 | $14M | 230k | 60.54 | |
Healthsouth | 0.7 | $13M | 265k | 48.40 | |
Aclaris Therapeutics (ACRS) | 0.6 | $12M | 440k | 27.12 | |
Beigene (BGNE) | 0.6 | $12M | 265k | 45.00 | |
RTI Biologics | 0.6 | $11M | 2.0M | 5.85 | |
Invitae (NVTAQ) | 0.6 | $12M | 1.2M | 9.56 | |
BioMarin Pharmaceutical (BMRN) | 0.6 | $11M | 125k | 90.82 | |
Dermira | 0.6 | $11M | 388k | 29.14 | |
Audentes Therapeutics | 0.6 | $11M | 595k | 19.13 | |
Ra Pharmaceuticals | 0.6 | $11M | 600k | 18.74 | |
Ardelyx (ARDX) | 0.5 | $10M | 2.0M | 5.10 | |
Ultragenyx Pharmaceutical (RARE) | 0.5 | $10M | 161k | 62.11 | |
Coherus Biosciences (CHRS) | 0.5 | $10M | 694k | 14.35 | |
Intersect Ent | 0.5 | $9.6M | 345k | 27.95 | |
Fibrogen (FGEN) | 0.5 | $9.0M | 280k | 32.30 | |
Ascendis Pharma A S (ASND) | 0.5 | $9.0M | 325k | 27.76 | |
Madrigal Pharmaceuticals (MDGL) | 0.4 | $8.8M | 540k | 16.26 | |
Therapeuticsmd | 0.4 | $8.4M | 1.6M | 5.27 | |
Clearside Biomedical (CLSD) | 0.4 | $8.5M | 935k | 9.11 | |
Alnylam Pharmaceuticals (ALNY) | 0.4 | $8.4M | 105k | 79.76 | |
CHINA CORD Blood Corp | 0.4 | $8.3M | 880k | 9.48 | |
Insmed (INSM) | 0.4 | $8.0M | 468k | 17.16 | |
Assembly Biosciences | 0.4 | $8.1M | 390k | 20.65 | |
Regeneron Pharmaceuticals (REGN) | 0.4 | $7.9M | 16k | 491.12 | |
Achillion Pharmaceuticals | 0.4 | $7.9M | 1.7M | 4.59 | |
Amicus Therapeutics (FOLD) | 0.4 | $7.6M | 758k | 10.07 | |
Retrophin | 0.4 | $7.8M | 400k | 19.39 | |
Biohaven Pharmaceutical Holding | 0.4 | $7.7M | 307k | 25.00 | |
Neuroderm Ltd F | 0.4 | $7.1M | 238k | 29.90 | |
Obseva Sa | 0.4 | $7.2M | 840k | 8.55 | |
Sarepta Therapeutics (SRPT) | 0.3 | $6.9M | 205k | 33.71 | |
Kite Pharma | 0.3 | $7.0M | 68k | 103.67 | |
Walgreen Boots Alliance (WBA) | 0.3 | $6.7M | 86k | 78.31 | |
Juno Therapeutics | 0.3 | $6.7M | 225k | 29.89 | |
Lexicon Pharmaceuticals (LXRX) | 0.3 | $6.5M | 394k | 16.45 | |
Axogen (AXGN) | 0.3 | $6.3M | 375k | 16.75 | |
Merus N V (MRUS) | 0.3 | $6.4M | 402k | 15.85 | |
Five Prime Therapeutics | 0.3 | $5.9M | 197k | 30.11 | |
Aimmune Therapeutics | 0.3 | $6.0M | 293k | 20.56 | |
Steris | 0.3 | $5.9M | 73k | 81.50 | |
Nabriva Therapeutics | 0.3 | $5.5M | 525k | 10.48 | |
Cardiome Pharma | 0.3 | $5.4M | 1.2M | 4.52 | |
Medicines Company 2.750000 07/15/2023 bond | 0.3 | $5.3M | 5.0M | 1.05 | |
G1 Therapeutics | 0.3 | $5.4M | 312k | 17.44 | |
Seattle Genetics | 0.3 | $5.2M | 100k | 51.74 | |
Corvus Pharmaceuticals (CRVS) | 0.3 | $5.1M | 423k | 12.10 | |
ACADIA Pharmaceuticals (ACAD) | 0.2 | $4.9M | 174k | 27.89 | |
Tetraphase Pharmaceuticals | 0.2 | $5.0M | 698k | 7.13 | |
Egalet Corporation note 5.50% 4/1/20 | 0.2 | $5.0M | 7.8M | 0.64 | |
Aduro Biotech | 0.2 | $4.7M | 415k | 11.40 | |
Exelixis (EXEL) | 0.2 | $4.3M | 175k | 24.63 | |
Allergan Plc pfd conv ser a | 0.2 | $4.3M | 5.0k | 867.20 | |
Global Blood Therapeutics In | 0.2 | $4.1M | 150k | 27.35 | |
Macrogenics (MGNX) | 0.2 | $3.9M | 225k | 17.51 | |
Otonomy | 0.2 | $4.0M | 210k | 18.85 | |
Adaptimmune Therapeutics (ADAP) | 0.2 | $3.9M | 875k | 4.49 | |
Medicines Company conv | 0.2 | $3.9M | 3.0M | 1.30 | |
Hill-Rom Holdings | 0.2 | $3.6M | 45k | 79.60 | |
Align Technology (ALGN) | 0.2 | $3.5M | 23k | 150.13 | |
Bluebird Bio (BLUE) | 0.2 | $3.4M | 32k | 105.06 | |
Compugen (CGEN) | 0.2 | $3.1M | 825k | 3.80 | |
Alkermes (ALKS) | 0.1 | $3.0M | 52k | 57.96 | |
Axovant Sciences | 0.1 | $2.9M | 125k | 23.19 | |
Bristol Myers Squibb (BMY) | 0.1 | $2.8M | 50k | 55.72 | |
Zimmer Holdings (ZBH) | 0.1 | $2.7M | 21k | 128.39 | |
Rigel Pharmaceuticals | 0.1 | $2.7M | 1.0M | 2.73 | |
Glycomimetics (GLYC) | 0.1 | $2.5M | 225k | 11.16 | |
Genocea Biosciences | 0.1 | $2.5M | 480k | 5.22 | |
Healthequity (HQY) | 0.1 | $2.5M | 51k | 49.82 | |
Dbv Technologies S A | 0.1 | $2.6M | 73k | 35.71 | |
Seres Therapeutics (MCRB) | 0.1 | $2.5M | 220k | 11.30 | |
Glaukos (GKOS) | 0.1 | $2.6M | 63k | 41.47 | |
Innoviva (INVA) | 0.1 | $2.6M | 200k | 12.80 | |
Intra Cellular Therapies (ITCI) | 0.1 | $2.3M | 188k | 12.42 | |
Alder Biopharmaceuticals | 0.1 | $2.1M | 182k | 11.45 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $2.3M | 300k | 7.50 | |
Proteostasis Therapeutics In | 0.1 | $2.1M | 450k | 4.68 | |
Aeglea Biotherapeutics | 0.1 | $2.0M | 524k | 3.84 | |
Theravance Biopharma Inc note 3.250%11/0 | 0.1 | $2.0M | 1.5M | 1.35 | |
Novadaq Technologies | 0.1 | $1.8M | 150k | 11.72 | |
Myovant Sciences | 0.1 | $1.8M | 150k | 11.70 | |
Dynavax Technologies (DVAX) | 0.1 | $1.6M | 165k | 9.65 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 0.1 | $1.6M | 475k | 3.40 | |
Scynexis | 0.1 | $1.4M | 760k | 1.79 | |
Nivalis Therapeutics | 0.1 | $1.4M | 600k | 2.41 | |
Wright Med Group Inc note 2.000% 2/1 | 0.1 | $1.1M | 1.0M | 1.12 | |
Novavax | 0.1 | $943k | 820k | 1.15 | |
Perrigo Company (PRGO) | 0.0 | $740k | 9.8k | 75.51 | |
Egalet | 0.0 | $711k | 300k | 2.37 | |
Chiasma | 0.0 | $714k | 493k | 1.45 | |
Newlink Genetics Corporation | 0.0 | $533k | 73k | 7.35 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $424k | 270k | 1.57 | |
Tandem Diabetes Care | 0.0 | $450k | 563k | 0.80 | |
Dimension Therapeutics | 0.0 | $394k | 271k | 1.45 | |
Orexigen Therapeutics | 0.0 | $479k | 165k | 2.90 | |
Cerulean Pharma | 0.0 | $275k | 625k | 0.44 | |
Anthera Pharmaceuticals (ANTH) | 0.0 | $268k | 166k | 1.62 |